# Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care

> **NCT03679182** · PHASE2 · UNKNOWN · sponsor: **Khon Kaen University** · enrollment: 15 (estimated)

## Conditions studied

- Nausea
- Vomiting
- End Stage Cancer

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT03679182
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-09
- **Final completion:** 2021-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679182, "Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03679182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*